DMAAU
Drugs Made In America Acquisition Corp.
Set alert
- YTD
- +4.96%
- 1 year
- +5.06%
- Open
- 0.00
- Prev close
- 11.01
- Mkt cap
- 261.73M
- Vol
- 0
- Avg vol
- 96
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 11.01
- High
- 11.01
News
8 months ago defenseworld.net
Drugs Made in America Acquisition (NASDAQ:DMAAU) Shares Down 0% – Time to Sell?
Drugs Made in America Acquisition Corp. (NASDAQ: DMAAU - Get Free Report) dropped 0% on Tuesday. The stock traded as low as $10.55 and last traded at $10.55. Approximately 600 shares changed hands…
9 months ago defenseworld.net
Drugs Made in America Acquisition (NASDAQ:DMAAU) Trading 0.2% Higher – What’s Next?
Drugs Made in America Acquisition Corp. (NASDAQ: DMAAU - Get Free Report) shares were up 0.2% during trading on Friday. The company traded as high as $10.52 and last traded at $10.52. Approximately…
10 months ago defenseworld.net
Drugs Made in America Acquisition (NASDAQ:DMAAU) Stock Price Down 0.6% – Here’s Why
Shares of Drugs Made in America Acquisition Corp. (NASDAQ: DMAAU - Get Free Report) were down 0.6% during trading on Thursday. The company traded as low as $10.49 and last traded at $10.49.…
1 year ago globenewswire.com
Drugs Made in America Acquisition Corp. Announces Advisory Team
Fort Lauderdale, FL, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Drugs Made in America Acquisition Corp. (Nasdaq: DMAAU), (the “Company”) today announced the formation of an advisory team to lead its effort…